Allervax Ragweed immunotherapeutic data

IMUL (Waltham, Mass.) announced Phase I results in 24 allergic individuals, saying the product was well tolerated at the doses tested, which ranged from 7.5 to 1500 µg per peptide. Phase II trials to ...